Adverse events and overall health and well-being after COVID-19 vaccination: interim results from the VAC4COVID cohort safety study.

ABSTRACT:

Objectives

To describe the incidence of adverse events (AEs), reactogenicity symptoms, menstrual changes and overall self-rated improvement in health and well-being after COVID-19 vaccination.

Design

VAC4COVID is an ongoing prospective, active observational, post-authorisation cohort safety study (PASS) of UK-approved vaccines for COVID-19 disease.

Setting

The study is conducted through a secure website (www.vac4covid.com) by MEMO Research, University of Dundee, UK.

Participants

16 265 adult (18 years or older) UK residents with a valid email address and internet access.

Interventions

Any UK-authorised COVID-19 vaccination.

Main outcome measures

The outcomes reported in this interim analysis include AEs, reactogenicity-type AEs (headache, fatigue,

SUBMITTER: Rogers A 

PROVIDER: S-EPMC9160588 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature